Mode
Text Size
Log in / Sign up

Small Intestine Cancer

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Small Intestine Cancer

7 trials tracked for Small Intestine Cancer.

7Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 4 Phase 1 1 Other / NA 2
  1. Phase 2 Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer Completed
  2. Phase 2 Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment Completed
  3. Phase 2 Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer Completed
  4. Phase 2 Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas Completed
  5. Phase 1 Vorinostat After Stem Cell Transplant in Treating Patients With High-Risk Lymphoma Completed
  6. N/A Programs To Support You During Chemotherapy Completed
Show 1 more trials
  1. N/A Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma Completed

Showing the 7 most-cited and recently-updated of 7 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.